Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967410 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant Mouse Abl Gag Fusion Protein
- Description
- Purified from tissue culture supernatant or ascites by affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 8-00E-09
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- 4°C
Submitted references BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.
Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.
Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JY, Arlinghaus RB
Blood 1994 Jun 15;83(12):3629-37
Blood 1994 Jun 15;83(12):3629-37
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB
Hematologic pathology 1993;7(2):91-106
Hematologic pathology 1993;7(2):91-106
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.
McWhirter JR, Wang JY
The EMBO journal 1993 Apr;12(4):1533-46
The EMBO journal 1993 Apr;12(4):1533-46
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
McWhirter JR, Wang JY
Molecular and cellular biology 1991 Mar;11(3):1553-65
Molecular and cellular biology 1991 Mar;11(3):1553-65
Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.
Guo JQ, Wang JY, Arlinghaus RB
Cancer research 1991 Jun 1;51(11):3048-51
Cancer research 1991 Jun 1;51(11):3048-51
Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.
Wang JY
Oncogene research 1988;3(3):293-8
Oncogene research 1988;3(3):293-8
Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Kipreos ET, Lee GJ, Wang JY
Proceedings of the National Academy of Sciences of the United States of America 1987 Mar;84(5):1345-9
Proceedings of the National Academy of Sciences of the United States of America 1987 Mar;84(5):1345-9
No comments: Submit comment
No validations: Submit validation data